-
Vertical integration of general practices with acute hospitals in England: rapid impact evaluation.
Health and Social Care Delivery Research, No. 11.17.
Sidhu M, Saunders CL, Davies C, et al.
Southampton (UK): National Institute for Health and Care Research; 2023 Oct.
-
Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop [Prepublication Draft].
Forum on Drug Discovery, Development, and Translation; Roundtable on Black Men and Black Women in Science, Engineering, and Medicine; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; U.S. Science and Innovation Policy; Health and Medicine Division; Policy and Global Affairs; National Academies of Sciences, Engineering, and Medicine.
Washington (DC): National Academies Press (US); 2024 May 16.
-
Cemiplimab (Libtayo): CADTH Reimbursement Recommendation: Indication: First-line treatment of adult patients with non–small cell lung cancer (NSCLC) expressing PD-L1 (Tumour Proportion Score [TPS] ≥ 50%), as determined by a validated test, with no EGFR, ALK, or ROS1 aberrations, who have locally advanced NSCLC who are not candidates for surgical resection or definitive chemoradiation, or metastatic NSCLC [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
-
Dapagliflozin for Chronic Kidney Disease: Rapid Review with Expert Input [Internet].
Khangura SD, Severn M; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
-
Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy: Rapid Review [Internet].
Lachance CC, Mierzwinski-Urban M; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
See more...
Image credit: SEM Penicillium mold and spores; David Gregory and Debbie Marshall, Wellcome Images